IntelliEPI Cayman Cash Flow Conversion Efficiency

Latest as of March 2026: 0.015x

IntelliEPI Cayman cash flow conversion efficiency. Based on the latest financial reports, IntelliEPI Cayman (4971) has a cash flow conversion efficiency ratio of 0.015x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$30.51 Million ≈ $961.36K USD) by net assets (NT$2.09 Billion ≈ $65.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of IntelliEPI Cayman (2011–2025)

Cash flow conversion efficiency of IntelliEPI Cayman from 2011 to 2025. This chart illustrates how IntelliEPI Cayman's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for IntelliEPI Cayman for real-time trading data and today's change.

IntelliEPI Cayman Cash Flow Conversion Ratio Explained

IntelliEPI Cayman cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

IntelliEPI Cayman Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of IntelliEPI Cayman ranked by their cash flow conversion efficiency. Also see market cap of IntelliEPI Cayman for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
CREDIT CORP. GROUP LTD.
F:2RC
N/A
Amper S.A.
MC:AMP
-0.602x
CellaVision AB
ST:CEVI
0.058x
Pony Testing International Group Co
SHE:300887
0.041x
Qinghai Huzhu Barley Wine Co Ltd
SHE:002646
0.000x
Raisecom Technology Co Ltd
SHG:603803
-0.004x
Everjoy Health Group Co Ltd
SHE:002162
0.048x
TPI Polene Public Company Limited
BK:TPIPL
0.015x

Annual Cash Flow Conversion Efficiency for IntelliEPI Cayman (2011–2025)

The table below shows the annual cash flow conversion efficiency of IntelliEPI Cayman from 2011 to 2025. Review 4971 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$2.02 Billion
≈ $63.56 Million
NT$234.84 Million
≈ $7.40 Million
0.116x +1094.63%
2024-12-31 NT$1.76 Billion
≈ $55.47 Million
NT$17.16 Million
≈ $540.54K
0.010x -82.17%
2023-12-31 NT$1.66 Billion
≈ $52.34 Million
NT$90.79 Million
≈ $2.86 Million
0.055x -61.97%
2022-12-31 NT$1.73 Billion
≈ $54.39 Million
NT$248.12 Million
≈ $7.82 Million
0.144x -5.94%
2021-12-31 NT$1.45 Billion
≈ $45.79 Million
NT$222.07 Million
≈ $7.00 Million
0.153x +171.37%
2020-12-31 NT$1.40 Billion
≈ $44.08 Million
NT$78.78 Million
≈ $2.48 Million
0.056x -40.92%
2019-12-31 NT$1.46 Billion
≈ $46.09 Million
NT$139.43 Million
≈ $4.39 Million
0.095x -1.28%
2018-12-31 NT$1.46 Billion
≈ $46.10 Million
NT$141.27 Million
≈ $4.45 Million
0.097x -23.87%
2017-12-31 NT$1.44 Billion
≈ $45.26 Million
NT$182.17 Million
≈ $5.74 Million
0.127x -5.90%
2016-12-31 NT$1.49 Billion
≈ $46.83 Million
NT$200.31 Million
≈ $6.31 Million
0.135x -22.23%
2015-12-31 NT$1.48 Billion
≈ $46.71 Million
NT$256.94 Million
≈ $8.10 Million
0.173x +1840.45%
2014-12-31 NT$1.00 Billion
≈ $31.61 Million
NT$8.96 Million
≈ $282.32K
0.009x -76.48%
2013-12-31 NT$800.25 Million
≈ $25.21 Million
NT$30.39 Million
≈ $957.48K
0.038x -88.64%
2012-12-31 NT$486.27 Million
≈ $15.32 Million
NT$162.49 Million
≈ $5.12 Million
0.334x +49.70%
2011-12-31 NT$423.95 Million
≈ $13.36 Million
NT$94.64 Million
≈ $2.98 Million
0.223x --

About IntelliEPI Cayman

TWO:4971 Taiwan Semiconductors
Market Cap
$490.05 Million
NT$15.55 Billion TWD
Market Cap Rank
#11971 Global
#441 in Taiwan
Share Price
NT$389.00
Change (1 day)
-9.95%
52-Week Range
NT$151.00 - NT$872.00
All Time High
NT$872.00
About

IntelliEPI Inc. (Cayman), together with its subsidiaries, produces and sells epitaxy wafers of compound semiconductor for use in wireless communications, data transmission and national defense in the United States, Germany, Korea, Japan, China, and internationally. The company utilizes its proprietary real-time in situ growth monitoring technology on molecular beam epitaxy (MBE) systems for the m… Read more